Perfil
Ruth B.
Kunath served a Director of Dendreon Corp.
from December 1999 to June 4, 2008.
She was Biotechnology Portfolio Manager of Vulcan, Inc. from 1991 to November 2003 and worked at Seattle Capital Management.
Ms. Kunath was Senior Portfolio Manager for the Healthcare Sector of Bank of America Capital Management.
She received a BA degree from DePauw University and is a Chartered Financial Analyst.
Antiguos cargos conocidos de Ruth B. Kunath.
| Empresas | Cargo | Fin |
|---|---|---|
| DENDREON CORPORATION | Director/Miembro de la Junta | 04/06/2008 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Ruth B. Kunath
